Cargando…
Combination treatment with VPA and MSCs-TRAIL could increase anti-tumor effects against intracranial glioma
Human bone marrow-derived mesenchymal stem cells secreting tumor necrosis factor-related apoptosis-inducing ligand (MSCs-TRAIL) have demonstrated effective anti-tumor activity against various tumors including lung, pancreatic and prostate tumors, although several tumor types are not responsive. In s...
Autores principales: | Park, Soon A., Han, Hye Rim, Ahn, Stephen, Ryu, Chung Heon, Jeun, Sin-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859926/ https://www.ncbi.nlm.nih.gov/pubmed/33469674 http://dx.doi.org/10.3892/or.2021.7937 |
Ejemplares similares
-
Possible Novel Therapy for Malignant Gliomas with Secretable Trimeric TRAIL
por: Jeong, Moonsup, et al.
Publicado: (2009) -
Combination Therapy for Gliomas Using Temozolomide and Interferon-Beta Secreting Human Bone Marrow Derived Mesenchymal Stem Cells
por: Park, Jae-Hyun, et al.
Publicado: (2015) -
Cytoplasmic Interactions between the Glucocorticoid Receptor and HDAC2 Regulate Osteocalcin Expression in VPA-Treated MSCs
por: La Noce, Marcella, et al.
Publicado: (2019) -
An Intracranial Chondroma with Intratumoral Hemorrhage: A Case Report and Review of the Literature
por: Park, Jae-Hyun, et al.
Publicado: (2013) -
Valproic Acid Downregulates the Expression of MGMT and Sensitizes Temozolomide-Resistant Glioma Cells
por: Ryu, Chung Heon, et al.
Publicado: (2012)